IRLAB COMPLETES RECRUITMENT FOR ITS PHASE... - Cure Parkinson's
IRLAB COMPLETES RECRUITMENT FOR ITS PHASE II STUDY WITH IRL790 IN PARKINSON’S DISEASE PATIENTS WITH DYSKINESIA
Written by
Farooqji
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Nilotinib Does Not Show Promise for Benefit in Phase II Nilotinib for Parkinson’s Disease (NILO-PD) Trial
Nilotinib seen to be safe and tolerable, but study strictly excluded those with heart issues or...
HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE 2016 (Treat it with folic acid?)
HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE 2016...
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...
6 Myths and Facts About Dyskinesia in Parkinson’s Disease
Here are a few of the most common myths and facts about levodopa and dyskinesia in Parkinson’s...
Patients with Parkinson’s disease (PD) report a strong craving for sweets
"Lately, studies have shown that patients with Parkinson’s disease (PD) report a strong craving...
Related Posts
- Tavapadon Lessens Motor Symptoms in Patients with Early-stage Parkinson’s, Phase 2 Trial Finds
STUDY: “High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease” 
Fecal microbiota transplantation (FMT) therapy for Parkinson’s disease - A preliminary study in China- Effects of Traditional Japanese Massage Therapy on Various Symptoms in Patients with Parkinson’s Disease:A Case-Series Study
FDA Approves Xadago (safinamide) as an Add-On Treatment for Patients with Parkinson’s Disease
